Travere Therapeutics Inc
Biotechnology
Healthcare
TVTX
77.78 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
15.28
52 week high
23.75
high
15.30
52 week low
13.49
previous Close
15.24
P/E ratio
market cap
1.49 B
div yield
0
net incoming
-54.81 M
22.15 %
net profit margin
-87.14 %
42.00 %
operating incoming
-54.75 M
18.34 %
net change in cash
4.12 M
137.57 %
cash on hand
36.41 M
12.75 %
cost of revenue
1.63 M
-86.89 %
top